Skip to main content
Home/Results/Retatrutide
RESULTS & WHAT TO TRACK

Retatrutide Results

Retatrutide produced the largest single-compound weight effect in published Phase 2 data. Because it is investigational and the glucagon arm adds a heart-rate consideration, the markers worth tracking go beyond the scale.

Why measurement beats a before/after photo

Retatrutide is investigational - which makes you the monitoring system. The weight effect is dramatic, but the glucagon-receptor activity also nudges resting heart rate and energy expenditure. Tracking the full picture (not just the scale) is how you run it responsibly and see what is actually happening to your body.

What to track on Retatrutide

Body weight + waist circumferenceWeeks 1-4 onward

Strong downtrend in trial data; waist tracks the fat-loss component.

Resting Heart RateDaily, from week 1

A 4-6 bpm rise was seen in Phase 2 (glucagon effect). Watch the trend vs your baseline.

Metabolic-response confirmation.

ALTBaseline + each dose plateau

Glucagon activity makes hepatic-enzyme monitoring worthwhile.

Retatrutide timeline: what tends to shift, when

Weeks 1-8

Escalation. Appetite suppression + early weight movement; resting heart rate may begin a modest climb.

Weeks 8-24

Higher doses. The largest weight effect in the literature accrues here; metabolic markers reflect the change.

Ongoing

Because it is research-grade, continuous RHR + periodic ALT/insulin tracking is the responsible cadence.

Signal vs placebo: how to tell a real result

For retatrutide, the resting-heart-rate trend is a signal you should not ignore - it is the glucagon arm showing up. Pair daily RHR (any wearable) with the 14-day weight trend and waist. The weight result will be obvious; the RHR and ALT trends are the ones that tell you whether the compound is pushing your cardiovascular or hepatic load in a direction worth discussing with a provider.

How to actually track Retatrutide results

This is the clearest case for tracking of any compound here: an investigational triple agonist where your own data is the monitoring layer. Log RHR daily, plot it against your dose timeline, and pull ALT + fasting insulin at baseline and each dose plateau. The scale tells you it is working; the RHR and labs tell you whether it is safe for you.

Track Retatrutide results with MyProtocolStack →
FULL PROFILE
Retatrutide overview & dosing →
WHAT TO WATCH
Retatrutide side effects →
FREE TOOL
Retatrutide dose calculator →

Results for other compounds

SemaglutideTirzepatideBPC-157TB-500TesamorelinIpamorelinCJC-1295SermorelinMK-677HGHGHK-CuPT-141EpithalonThymosin Alpha-1MOTS-c
This page is for educational purposes only and is not medical advice. It describes what to measure and what published literature and mechanism suggest about timing - it does not promise or predict any specific result for any individual. Do not start, stop, or change any peptide, GLP-1, hormone, or medication without consulting your licensed healthcare provider. MyProtocolStack is a tracking and education platform - it does not diagnose, treat, cure, or prevent any condition.